Common Genetic Polymorphisms and Coronary Heart Disease

 

 Buy Article Permissions and Reprints

ABSTRACT

Susceptibility to coronary heart disease (CHD) is to some extent genetically determined, but despite a great deal of effort, in the past decade research has shown little progress towards identifying the genetic variants responsible. This article explores the reasons why this is so, using the ACE insertion/deletion polymorphism, which has been the most extensively studied of all genetic polymorphisms with respect to CHD risk, as an example. It is suggested that issues long recognized as important in epidemiological studies of classical risk factors, such as appropriate sample size, a requirement for high levels of statistical significance, and avoidance of excessive subgroup analysis, have tended to be under-appreciated in case-control studies of genetic polymorphisms and disease thus far. I discuss the consequences of such methodological limitations. Finally, I present a ``checklist'' of important factors in study design and analysis in order to assist readers who may be unfamiliar with aspects of genetic methodology in the evaluation of these increasingly frequently conducted studies.

REFERENCES

• 1 Marenberg M E, Risch N, Berkman L F. Genetic susceptibility to death from coronary heart disease in a study of twins.  N Engl J Med . 1994;  330(15) 1041-1046
  CrossrefPubMedGoogle Scholar
• 2 Shea S, Ottman R, Gabrieli C. Family history as an independent risk factor for coronary artery disease.  J Am Coll Cardiol . 1984;  4(4) 793-801
  PubMedGoogle Scholar
• 3 Parish S, Collins R, Peto R. Cigarette smoking, tar yields, and nonfatal myocardial infarction: 14,000 cases and 32,000 controls in the United Kingdom. The International Studies of Infarct Survival (ISIS) Collaborators.  BMJ . 1995;  311(7003) 471-477
  PubMedGoogle Scholar
• 4 Osler M, Holst C, Prescott E. Influence of genes and family environment on adult smoking behavior assessed in an adoption study.  Genet Epidemiol . 2001;  21(3) 193-200
  CrossrefPubMedGoogle Scholar
• 5 Jang K L, Vernon P A, Livesley W J. Intra- and extra-familial influences on alcohol and drug misuse: a twin study of gene-environment correlation.  Addiction . 2001;  96(9) 1307-1318
  CrossrefPubMedGoogle Scholar
• 6 Williams R R, Hunt S C, Hopkins P N. Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah.  Am J Hypertens . 1993;  6(11 Pt 2) 319S-327S
  PubMedGoogle Scholar
• 7 Vinck W J, Fagard R H, Loos R. The impact of genetic and environmental influences on blood pressure variance across age-groups.  J Hypertens . 2001;  19(6) 1007-1013
  CrossrefPubMedGoogle Scholar
• 8 Poulsen P, Vaag A, Kyvik K. Genetic versus environmental aetiology of the metabolic syndrome among male and female twins.  Diabetologia . 2001;  44(5) 537-543
  CrossrefPubMedGoogle Scholar
• 9 Mitchell B D, Kammerer C M, Blangero J. Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. The San Antonio Family Heart Study.  Circulation . 1996;  94(9) 2159-2170
  PubMedGoogle Scholar
• 10 Lamon-Fava S, Wilson P W, Schaefer E J. Impact of body mass index on coronary heart disease risk factors in men and women. The Framingham Offspring Study.  Arterioscler Thromb Vasc Biol . 1996;  16(12) 1509-1515
  PubMedGoogle Scholar
• 11 Nora J J, Lortscher R H, Spangler R D. Genetic-epidemiologic study of early-onset ischemic heart disease.  Circulation . 1980;  61(3) 503-508
  PubMedGoogle Scholar
• 12 zur Lage P, Shrimpton A D, Flavell A J. Genetic and molecular analysis of smooth, a quantitative trait locus affecting bristle number in Drosophila melanogaster.  Genetics . 1997;  146(2) 607-618
  PubMedGoogle Scholar
• 13 Mackay T F. The nature of quantitative genetic variation revisited: lessons from Drosophila bristles.  Bioessays . 1996;  18(2) 113-121
  CrossrefPubMedGoogle Scholar
• 14 Keavney B, McKenzie C A, Connell J M. Measured haplotype analysis of the angiotensin-I converting enzyme gene.  Hum Mol Genet . 1998;  7(11) 1745-1751
  CrossrefPubMedGoogle Scholar
• 15 Austin M A, Sandholzer C, Selby J V. Lipoprotein(a) in women twins: heritability and relationship to apolipoprotein(a) phenotypes.  Am J Hum Genet . 1992;  51(4) 829-840
  PubMedGoogle Scholar
• 16 Boomsma D I, Kaptein A, Kempen H J. Lipoprotein(a): relation to other risk factors and genetic heritability. Results from a Dutch parent-twin study.  Atherosclerosis . 1993;  99(1) 23-33
  CrossrefPubMedGoogle Scholar
• 17 Bell J I, Lathrop G M. Multiple loci for multiple sclerosis.  Nat Genet . 1996;  13(4) 377-378
  PubMedGoogle Scholar
• 18 Haines J L, Ter-Minassian M, Bazyk A. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group.  Nat Genet . 1996;  13(4) 469-471
  PubMedGoogle Scholar
• 19 Ebers G C, Kukay K, Bulman D E. A full genome search in multiple sclerosis.  Nat Genet . 1996;  13(4) 472-476
  PubMedGoogle Scholar
• 20 Kuokkanen S, Gschwend M, Rioux J D. Genomewide scan of multiple sclerosis in Finnish multiplex families.  Am J Hum Genet . 1997;  61(6) 1379-1387
  CrossrefPubMedGoogle Scholar
• 21 Sawcer S, Jones H B, Feakes R. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22.  Nat Genet . 1996;  13(4) 464-468
  PubMedGoogle Scholar
• 22 Concannon P, Gogolin-Ewens K J, Hinds D A. A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus.  Nat Genet . 1998;  19(3) 292-296
  PubMedGoogle Scholar
• 23 Davies J L, Kawaguchi Y, Bennett S T. A genome-wide search for human type 1 diabetes susceptibility genes.  Nature . 1994;  371(6493) 130-136
  CrossrefPubMedGoogle Scholar
• 24 Field L L, Tobias R, Magnus T. A locus on chromosome 15q26 (IDDM3) produces susceptibility to insulin-dependent diabetes mellitus.  Nat Genet . 1994;  8(2) 189-194
  PubMedGoogle Scholar
• 25 Hashimoto L, Habita C, Beressi J P. Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q.  Nature . 1994;  371(6493) 161-164
  CrossrefPubMedGoogle Scholar
• 26 Horikawa Y, Oda N, Cox N J. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus.  Nat Genet . 2000;  26(2) 163-175
  Google Scholar
• 27 Hugot J P, Chamaillard M, Zouali H. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.  Nature . 2001;  411(6837) 599-603
  CrossrefPubMedGoogle Scholar
• 28 Hampe J, Cuthbert A, Croucher P J. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations.  Lancet . 2001;  357(9272) 1925-1928
  CrossrefPubMedGoogle Scholar
• 29 Ogura Y, Bonen D K, Inohara N. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.  Nature . 2001;  411(6837) 603-606
  CrossrefPubMedGoogle Scholar
• 30 Risch N, Merikangas K. The future of genetic studies of complex human diseases.  Science . 1996;  273(5281) 1516-1517
  CrossrefPubMedGoogle Scholar
• 31 Risch N J. Searching for genetic determinants in the new millennium.  Nature . 2000;  405(6788) 847-856
  CrossrefPubMedGoogle Scholar
• 32 Keavney B, McKenzie C, Parish S. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators.  Lancet . 2000;  355(9202) 434-442
  PubMedGoogle Scholar
• 33 Lahoz C, Schaefer E J, Cupples L A. Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study.  Atherosclerosis . 2001;  154(3) 529-537
  CrossrefPubMedGoogle Scholar
• 34 Ridker P M, Hennekens C H, Schmitz C. PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis.  Lancet . 1997;  349(9049) 385-388
  CrossrefPubMedGoogle Scholar
• 35 Davignon J, Cohn J S, Mabile L. Apolipoprotein E and atherosclerosis: insight from animal and human studies.  Clinica Chimica Acta . 1999;  286 115-143
  CrossrefPubMedGoogle Scholar
• 36 Wilson P W, Schaefer E J, Larson M G. Apolipoprotein E alleles and risk of coronary disease. A meta-analysis.  Arterioscler Thromb Vasc Biol . 1996;  16(10) 1250-1255
  PubMedGoogle Scholar
• 37 Keavney B, Youngman L D, Palmer A. Large-scale test of hypothesized associations between polymorphisms of lipid-related genes and myocardial infarction in about 5000 cases and 6000 controls.  Circulation . 2000;  250-251
  PubMedGoogle Scholar
• 38 Cambien F, Alhenc-Gelas F, Herbeth B. Familial resemblance of plasma angiotensin-converting enzyme level: The Nancy Study.  Am J Hum Genet . 1988;  43(5) 774-780
  PubMedGoogle Scholar
• 39 Cambien F, Poirier O, Lecerf L. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction.  Nature . 1992;  359(6396) 641-644
  CrossrefPubMedGoogle Scholar
• 40 Humphries S E, Talmud P J, Hawe E. Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study.  Lancet . 2001;  358(9276) 115-119
  CrossrefPubMedGoogle Scholar
• 41 Collins A, Lonjou C, Morton N E. Genetic epidemiology of single-nucleotide polymorphisms.  Proc Natl Acad Sci U S A . 1999;  96(26) 15173-15177
  CrossrefPubMedGoogle Scholar
• 42 Collins A, Morton N E. Mapping a disease locus by allelic association.  Proc Natl Acad Sci U S A . 1998;  95(4) 1741-1745
  CrossrefPubMedGoogle Scholar